Comparison of topical benzyl benzoate vs. oral ivermectin in treating scabies: A randomized study.

Damian Meyersburg Tobias WelponerAndreas KaiserSylvia SelhoferRafaella TatarskiAlessandra HandisuryaJohannes Wolfgang Bauer

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)

Topical BB and oral ivermectin have shown comparable good therapeutic efficacy. Therefore, both agents constitute an adequate first-line therapy in the treatment of scabies. A combination of both agents may be considered in recalcitrant and extensively infested cases, additionally to crusted scabies.

Keyphrases

wound healing
multidrug resistant
growth factor
drug administration
stem cells
combination therapy
clinical evaluation